Schonfeld Strategic Advisors LLC Esperion Therapeutics, Inc. Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 847,727 shares of ESPR stock, worth $1.81 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

847,727

Previous 947,506 10.53%

Holding current value

$1.81 Million

Previous $2.54 Million 25.92%

% of portfolio

0.01%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.84 - $3.24 $183,593 - $323,283	-99,779 Reduced 10.53%	847,727 $1.88 Million
Q1 2024 May 15, 2024	SELL	$2.02 - $3.02 $290,520 - $434,342	-143,822 Reduced 13.18%	947,506 $2.54 Million
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $102,564 - $432,736	-140,499 Reduced 11.41%	1,091,328 $3.26 Million
Q3 2023 Nov 14, 2023	SELL	$0.96 - $1.79 $80,902 - $150,848	-84,273 Reduced 6.4%	1,231,827 $1.21 Million
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $592,573 - $869,107	-493,811 Reduced 27.28%	1,316,100 $1.83 Million
Q1 2023 May 15, 2023	BUY	$1.46 - $7.3 $1.61 Million - $8.05 Million	1,102,859 Added 155.98%	1,809,911 $2.88 Million
Q4 2022 Feb 14, 2023	SELL	$5.09 - $8.5 $488,726 - $816,144	-96,017 Reduced 11.96%	707,052 $4.4 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $4.05 Million - $6.04 Million	743,069 Added 1238.45%	803,069 $5.38 Million
Q2 2022 Aug 15, 2022	SELL	$4.77 - $6.67 $223,712 - $312,823	-46,900 Reduced 43.87%	60,000 $382,000
Q1 2022 May 16, 2022	SELL	$3.34 - $5.56 $612,556 - $1.02 Million	-183,400 Reduced 63.18%	106,900 $496,000
Q4 2021 Feb 14, 2022	BUY	$4.81 - $11.92 $1.33 Million - $3.3 Million	276,543 Added 2010.2%	290,300 $1.45 Million
Q3 2021 Nov 16, 2021	SELL	$11.34 - $21.37 $525,132 - $989,601	-46,308 Reduced 77.1%	13,757 $166,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $1.17 Million - $1.72 Million	60,065 New	60,065 $1.27 Million
Q4 2019 Feb 14, 2020	SELL	$35.4 - $59.82 $6.44 Million - $10.9 Million	-182,019 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$34.47 - $47.53 $6.27 Million - $8.65 Million	182,019 New	182,019 $6.67 Million
Q1 2018 May 15, 2018	SELL	$65.94 - $80.76 $215,294 - $263,681	-3,265 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$43.47 - $67.43 $141,929 - $220,158	3,265	3,265 $215,000

Others Institutions Holding ESPR

# of Institutions

197

Shares Held

136M

Call Options Held

2.72M

Put Options Held

1.3M

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $142M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Esperion Therapeutics, Inc. Transaction History